A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients

Bibliographic Details
Title: A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients
Authors: Ann J. Ligocki, Jacqueline R. Rivas, William H. Rounds, Alyssa A. Guzman, Min Li, Melania Spadaro, Lauren Lahey, Ding Chen, Paul M. Henson, Donna Graves, Benjamin M. Greenberg, Elliot M. Frohman, E. Sally Ward, William Robinson, Edgar Meinl, Charles L. White, Ann M. Stowe, Nancy L. Monson
Source: ASN Neuro, Vol 7 (2015)
Publisher Information: Taylor & Francis, 2015.
Publication Year: 2015
Collection: LCC:Neurosciences. Biological psychiatry. Neuropsychiatry
Subject Terms: Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571
More Details: * These authors contributed equally to the work in this manuscript. We have previously identified a distinct class of antibodies expressed by B cells in the cerebrospinal fluid (CSF) of early and established relapsing remitting multiple sclerosis (RRMS) patients that is not observed in healthy donors. These antibodies contain a unique pattern of mutations in six codons along V H 4 antibody genes that we termed the antibody gene signature (AGS). In fact, patients who have such B cells in their CSF are identified as either having RRMS or developing RRMS in the future. As mutations in antibody genes increase antibody affinity for particular antigens, the goal for this study was to investigate whether AGS + antibodies bind to brain tissue antigens. Single B cells were isolated from the CSF of 10 patients with early or established RRMS. We chose 32 of these B cells that expressed antibodies enriched for the AGS for further study. We generated monoclonal full-length recombinant human antibodies (rhAbs) and used both immunological assays and immunohistochemistry to investigate the capacity of these AGS + rhAbs to bind brain tissue antigens. AGS + rhAbs did not recognize myelin tracts in the corpus callosum. Instead, AGS + rhAbs recognized neuronal nuclei and/or astrocytes, which are prevalent in the cortical gray matter. This pattern was unique to the AGS + antibodies from early and established RRMS patients, as AGS + antibodies from an early neuromyelitis optica patient did not display the same reactivity. Prevalence of CSF-derived B cells expressing AGS + antibodies that bind to these cell types may be an indicator of gray matter-directed autoimmunity in early and established RRMS patients.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1759-0914
17590914
Relation: https://doaj.org/toc/1759-0914
DOI: 10.1177/1759091415609613
Access URL: https://doaj.org/article/0818d081b648490abbd33a5fbccc8be2
Accession Number: edsdoj.0818d081b648490abbd33a5fbccc8be2
Database: Directory of Open Access Journals
More Details
ISSN:17590914
DOI:10.1177/1759091415609613
Published in:ASN Neuro
Language:English